1. King JA, Davidson J, Mehl Al, Wakefield IK, Andersson P-B and Millar RP (1989) Gonadal steroid modulation of signal transduction and luteinising hormone release in cultured chicken pituitary cells. endocrinology 124, 1830-1840.

2. Hudson DA, Andersson P-B, Krige JE and Terblanche J (1990) Perihepatic packing in liver rupture during pregnancy. Journal of Obstetrics and Gynaecology 9, 298-299.

3. Andersson P-B, Perry VH and Gordon S (1991) The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42, 201-214.

4. Andersson P-B, Perry V.H. and Gordon S. (1991) The CNS acute inflammatory response to excitotoxic neuronal cell dealth. Immunology Letters 30, 177-183.

5. Andersson P-B, Perry V.H. and Gordon S (1992) The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48, 169-186.

6. Perry V.H. and Andersson P-B. (1992) The inflammatory response in the CNS. Neuropathology and Applied Neurobiology 18, 454-459.

7. Andersson P-B, Perry V.H. and Gordon S. (1992) Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. Journal of Experimental Medicine 176, 255-259.

8. Perry V.H., Andersson P-B, and Gordon S. (1993) Macrophages and inflammation in the central nervous system. Trends in the Neurosciences 16, 268-273.

9. Reid D.M, Andersson P-B and Gordon S. (1993) Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience 56, 529-233.

10. Andersson P-B and Goodkin D.E. (1996) Current Pharmacologic Treatment of Multiple Sclerosis Symptoms. Western J. Medicine 165, 313-317.

11. Andersson P-B, Waubant E and Goodkin D.E. (1997) How should we proceed with disease- modifying treatments for multiple sclerosis? Lacet. 349, 586-587.

12. Andersson P-B, Waubant E and Goodkin D.E. (1997) Outcomes assessment in multiple sclerosis. In Bailliere's Clinical Neurology. Vol 6 Multiple Sclerosis, Miller DH (ed). Bailliere Tindall, London. pp 409-428.

13. Andersson P-B, and Goodkin D.E. (1997) Glucocorticosteroid therapy for multiple sclerosis: a critical review. Journal of the Neurological Sciences. 16, 16-25.

14. Andersson P-B, Waubant E, Gee L, Goodkin D.E. (1999) Multiple Sclerosis that is progressive from the time of onset: Clinical characteristics and progression of disability. Archives of Neurology. 56, 1138-1142.

15. Waubant E, Goodkin D.E., Sloan R, Andersson P-B, (1999) A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 53, 874-876.

16. Waubant E, Gee L, Sloan R, Rooney W, Andersson P-B, Stewart T, Vermathen M, Stabler G, Miller K, Goodkin D (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53, 1397-1401.

17. Waubant E, Sloan R, Andersson P-B, Goodkin D.E., (1999) [Effect of weekly intramuscular interferon beta 1-a on MRI lesions in patients with relapsing multiple sclerosis. Rev Neurol (Paris) 155 Sup 2 S20-23.

18. Andersson P-B, Rando T. (1999) Childhood Neuromuscular diseases. Current Opinion in Pediatrics. 11, 497-503.

19. Katz JS, Wolfe GI, Andersson P-B, Saperstein Ds, Elliot JL, Nations SP, Bryan WW, Barohn RJ (1999) Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 53, 1071-1076.

20. Suhy J, rooney WD, Goodkin DE, Capizzano AA, Maudsley AA, Waubant E, Andersson P-B, Weiner MW (2000) 1H-MRS of normal appearing white matter and lesions in primary progressive MS: Comparison with relapsing remitting MS. Multiple Sclerosis 6, 148-155.

21. Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P-B, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. (2000) A phase I trial of solubilized DR2: MBP 84-102 (AG284) in multiple sclerosis. Neurology. 54, 1414-20.

22. Tregoning SK, Ballard RC, Andersson P-B, Fehler HG, Van Der Spuy ZM (2000) Antibodies to Chlymadia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital. S Afr Med. J. 90, 727-730.

23. Andersson P-B, Yuen E, Katz JS, Parko K, So YT (2000) The differentiating electrophysiologic characteristics of hereditary neuropathy with liability to pressure palsy. Neurology. 54, 40-44.

24. Lin P.T., Andersson P-B, Distad BJ, Barohn RJ, Cho SC, So YT, Katz JS (2005) Bilateral phrenic neuropathy causing painless bilateral diaphragmatic paralysis. Neurology 65, 499-501. 


Tel: (818) 221-2000

Fax: 310-634-1259